Nutranomics, Inc. (NNRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 14, 2025
Nutranomics Revenue
In the fiscal year ending July 31, 2020, Nutranomics had annual revenue of $871.00, down -98.54%.
Revenue
871.00
Revenue Growth
-98.54%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
16.75K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
American Oncology Network | 1.76B |
BioStem Technologies | 301.83M |
Nutranomics News
- 2 years ago - NutraNomics Announces Exclusive Production Agreement with Premium Edibles Brand - Accesswire
- 2 years ago - The Plant Announces Strategic Business Alliance With RE Strategies, LLC - Accesswire
- 2 years ago - NutraNomics and The Plant Well Positioned for Growth Despite "Black Market" Competition - Accesswire
- 2 years ago - NutraNomics, Inc. and The Plant Announce Record October 2022 New Sales Bookings - Accesswire
- 2 years ago - NutraNomics Announces 109% Y/Y Growth for the Nine Months Ended September 30, 2022 - Accesswire
- 2 years ago - NutraNomics, Inc. and The Plant Announce Record Q3 2022 New Sales Bookings - Accesswire
- 2 years ago - NutraNomics Announces Debt Restructuring and New Credit Facility - Accesswire
- 2 years ago - NutraNomics, Inc. and The Plant Announce Distribution Expansion Into Northern California - Accesswire